Cure My Disease

Don't miss your cure!

 Log in / Sign up

One simple score to rate colorectal cancer surgery quality?

NCT ID NCT07718919

Knowledge-focused Sponsor: Academy of Applied Medical and Social Sciences, Poland Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 22, 2026 · Last updated Jul 23, 2026 · Updated 1 time

Summary

This large Italian study investigates whether a composite measure called 'Textbook Outcome' can serve as a reliable indicator of quality in colorectal cancer surgery. Researchers will analyze data from over 6,000 patients to see if meeting six key criteria—including survival, complete tumor removal, and no major complications—predicts better long-term outcomes. The goal is to identify factors that prevent surgeons from achieving this ideal outcome and to improve care standards.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could establish a simple, reliable quality benchmark for colorectal cancer surgery, helping hospitals identify areas for improvement and potentially improving patient outcomes.
What could go wrong
This is an observational, retrospective study, so it cannot prove cause and effect. The Textbook Outcome definition may not capture all important aspects of care, and results may not apply outside Italy.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

6,129 people

The number who actually took part.

Started

Jan 2022

Finished

Jun 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

all consecutive adult patients (aged 18 years and older) admitted to participating surgical departments with a diagnosis of colorectal cancer submitted to colorectal cancer surgery

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults aged 18 years or older at the time of diagnosis. * An ASA (American Society of Anesthesiology) classification of less than 4, indicating patients who are in relatively good health and can tolerate major surgery. * Histologically confirmed diagnosis of colorectal carcinoma, ensuring that only patients with verified malignant disease are included. * Absence of distant metastases (M0 stage), allowing the study to focus on patients eligible for curative surgery. * Patients who underwent curative resection, encompassing both elective and emergency surgical cases. Exclusion Criteria: * Patients who are preoperatively, intraoperatively, or postoperatively staged as M1, indicating the presence of distant metastases, as these cases typically involve palliative rather than curative treatment strategies. * Patients with a history of prior colectomy, as previous surgeries may complicate the assessment of current treatment outcomes. * Patients who underwent palliative treatments, as the study aims to evaluate curative-intent surgeries.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Colo-rectal cancer are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

colonic neoplasm colorectal cancer colorectal carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Colo-rectal cancer

Contacts and locations

Locations

  • ACOI

    Cagliari, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.